Features of polycythemia vera in the 8p12 myeloproliferative syndrome

Jeanna L Welborn, Shelly Fenner, Robert Parks

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The 8p12 myeloproliferative syndrome is a distinct myeloid disorder associated with a translocation involving chromosome region 8p12 (HUGO nomenclature). It is characterized by leukocytosis, eosinophilia, and a concurrent or rapid transformation to a T-cell lymphoblastic lymphoma. We report a case of polycythemia vera as a clinical presentation of the 8p12 myeloproliferative syndrome and review the literature. Atypical features in patients with polycythemia vera should be investigated with cytogenetic evaluation.

Original languageEnglish (US)
Pages (from-to)53-55
Number of pages3
JournalCancer Genetics and Cytogenetics
Volume199
Issue number1
DOIs
StatePublished - May 2010

Fingerprint

Polycythemia Vera
T-Cell Lymphoma
Leukocytosis
Eosinophilia
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Terminology
Cytogenetics
Chromosomes

ASJC Scopus subject areas

  • Cancer Research
  • Genetics
  • Molecular Biology

Cite this

Features of polycythemia vera in the 8p12 myeloproliferative syndrome. / Welborn, Jeanna L; Fenner, Shelly; Parks, Robert.

In: Cancer Genetics and Cytogenetics, Vol. 199, No. 1, 05.2010, p. 53-55.

Research output: Contribution to journalArticle

Welborn, Jeanna L ; Fenner, Shelly ; Parks, Robert. / Features of polycythemia vera in the 8p12 myeloproliferative syndrome. In: Cancer Genetics and Cytogenetics. 2010 ; Vol. 199, No. 1. pp. 53-55.
@article{226ed221ca9b4fd2bc9039135cab594b,
title = "Features of polycythemia vera in the 8p12 myeloproliferative syndrome",
abstract = "The 8p12 myeloproliferative syndrome is a distinct myeloid disorder associated with a translocation involving chromosome region 8p12 (HUGO nomenclature). It is characterized by leukocytosis, eosinophilia, and a concurrent or rapid transformation to a T-cell lymphoblastic lymphoma. We report a case of polycythemia vera as a clinical presentation of the 8p12 myeloproliferative syndrome and review the literature. Atypical features in patients with polycythemia vera should be investigated with cytogenetic evaluation.",
author = "Welborn, {Jeanna L} and Shelly Fenner and Robert Parks",
year = "2010",
month = "5",
doi = "10.1016/j.cancergencyto.2010.01.013",
language = "English (US)",
volume = "199",
pages = "53--55",
journal = "Cancer Genetics and Cytogenetics",
issn = "0165-4608",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Features of polycythemia vera in the 8p12 myeloproliferative syndrome

AU - Welborn, Jeanna L

AU - Fenner, Shelly

AU - Parks, Robert

PY - 2010/5

Y1 - 2010/5

N2 - The 8p12 myeloproliferative syndrome is a distinct myeloid disorder associated with a translocation involving chromosome region 8p12 (HUGO nomenclature). It is characterized by leukocytosis, eosinophilia, and a concurrent or rapid transformation to a T-cell lymphoblastic lymphoma. We report a case of polycythemia vera as a clinical presentation of the 8p12 myeloproliferative syndrome and review the literature. Atypical features in patients with polycythemia vera should be investigated with cytogenetic evaluation.

AB - The 8p12 myeloproliferative syndrome is a distinct myeloid disorder associated with a translocation involving chromosome region 8p12 (HUGO nomenclature). It is characterized by leukocytosis, eosinophilia, and a concurrent or rapid transformation to a T-cell lymphoblastic lymphoma. We report a case of polycythemia vera as a clinical presentation of the 8p12 myeloproliferative syndrome and review the literature. Atypical features in patients with polycythemia vera should be investigated with cytogenetic evaluation.

UR - http://www.scopus.com/inward/record.url?scp=77951899992&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951899992&partnerID=8YFLogxK

U2 - 10.1016/j.cancergencyto.2010.01.013

DO - 10.1016/j.cancergencyto.2010.01.013

M3 - Article

C2 - 20417870

AN - SCOPUS:77951899992

VL - 199

SP - 53

EP - 55

JO - Cancer Genetics and Cytogenetics

JF - Cancer Genetics and Cytogenetics

SN - 0165-4608

IS - 1

ER -